Lilly Asia Ventures key facts
- Lilly Asia Ventures is a venture capital firm based in Hong Kong, Hong Kong with 8 tracked portfolio companies.
- Notable positions include InSilico Medicine Cayman (HKG: 03696), Caidya, Avenzo Therapeutics.
- Lilly Asia Ventures has 1 fund on record, raising $100.0M across the 1 that report a size.
About Lilly Asia Ventures
Founded in 2008, Lilly Asia Ventures is a corporate venture capital arm of Eli Lilly headquartered in Hongkong. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in healthcare, life sciences, manufacturing, the internet of things, oncology, and technology-based sectors in China and the United States.
Lilly Asia Ventures portfolio at a glance
8 portfolio companies are on record for Lilly Asia Ventures, including InSilico Medicine Cayman (HKG: 03696), Caidya and Avenzo Therapeutics.
6 of the 8 carry a recorded valuation.
Lilly Asia Ventures funds
1 fund is on record for Lilly Asia Ventures, totalling $100 million across the 1 that report a size. The most recent is Lilly Asia Ventures Fund III, L.P. (2015 vintage), $100 million.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 8 recorded positions
- ·Watchlist + alerts for Lilly Asia Ventures's activity
Portfolio
8 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| InSilico Medicine Cayman (HKG: 03696) | Biotech | ▮ | ▮ | ▮ |
| Caidya | Other Healthcare Services | ▮ | ▮ | ▮ |
| Avenzo Therapeutics | — | ▮ | ▮ | ▮ |
+ 5 more companies · all 8, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Funds
1 recorded- Lilly Asia Ventures Fund III, L.P.2015$100.0M
$100.0M raised across the 1 fund that report a size
Frequently asked about Lilly Asia Ventures
- What companies does Lilly Asia Ventures invest in?
- Lilly Asia Ventures has 8 recorded portfolio companies, including InSilico Medicine Cayman (HKG: 03696), Caidya, Avenzo Therapeutics.
- What is Lilly Asia Ventures's AUM?
- Lilly Asia Ventures manages approximately $5.6B in assets.